Cancer Markers - Market Research, Industry Trends, Market Share


Published: 03/24/2016
Pages: 155
Full Study Price: US$ 2,500

Cancer Markers provides market assessment, estimates, and competitive analysis for oncology tests which incorporate biomarkets. These test have demonstrated faster revenue growth than in vitro diagnostics (IVD) broadly, and drawn considerable interest from markets competitors. Cancer Markers examines those products which are designed to determine risk for cancer, screen for cancer, test for cancer, aid in prognosis and personalize therapy. Technologies discussed in this report: Histology/Cytology; Immunohistochemistry In situ hybridization Immunoassays - Tumor Markers; Flow Cytometry Rapid Tests; and Molecular Marker-Based.
Estimates for these segments are provided for 2015 and 2020. Cancer Markers provides some specific marker breakouts along with significant detail of products on the market. The various clinical techniques and trends are discussed from the point of view of their present and potential market impact. This report does not provide an in-depth discussion of the etiology, physiology and clinical manifestations of diseases except where an understanding of these areas is required to understand the impact that new and early diagnostics exert on patient care. Cancer Markers does not describe the technical aspects of the test modalities used in PMx tests. This report presents data derived on publicly available information sources such as company, government, and medical organization reports. The analysis is based on the author's industry knowledge combined with literature searches and interviews with industry professionals and experts in the areas of in vitro diagnostics and personalized medicine.
Our Simple Buying Process

Choose License and Add
This Report To Your Cart.

Register, Checkout
and Verify Payment.

Receive Notification When
Your Report Is Available.

Table Of Contents

  • Executive Summary
    • MARKET
    • SCOPE AND METHODOLOGY
  • Introduction
    • Table Estimated Global Incidence and Mortality due to Cancer, 2012 – By Regions of the World
    • Table Selected Widely Used Tumor Markers
    • CANCER RISK ASSESSMENT
      • Table Selected Biomarkers and Biomarker Panels to Assess Risk of Cancer, and Companies Developing/Marketing These Biomarkers
    • CANCER SCREENING
      • Table Selected Biomarkers and Biomarker Panels for Cancer Screening, and Companies Developing/Marketing These Biomarkers
    • CANCER MONITORING
      • Table Selected Biomarkers and Biomarker Panels for Diagnosis and/or Monitoring of Cancer, and Companies Developing/Marketing These Biomarkers
    • CANCER PROGNOSIS ASSESSMENT
      • Table Selected Biomarkers and Biomarker Panels to Predict Prognosis of Cancer, and Companies Developing/Marketing These Biomarkers
    • PERSONALIZED MEDICINE/PRECISION TESTING
      • Table Selected Biomarkers and Biomarker Panels to Predict Response to Therapy, and Companies Developing/Marketing These Biomarkers
      • Table Selected FDA Cleared/Approved Companion Diagnostic Tests, and Companies Developing/Marketing These Biomarkers
    • COMPETITION IN CANCER BIOMARKERS
      • Table Selected Companies Developing/Marketing Cancer Tests
    • MOLECULAR MARKERS
      • Table Common Next Generation Molecular Test Traits
    • PRECISION MEDICINE
      • Table Selected Sample Preparation Reagents
      • Table Selected Cancer Test Innovations, 2015
  • Cancer Markers Market Analysis
    • Table Worldwide Cancer Biomarkers Diagnostic Market – 2015 and 2020 (IHC, ISH, Immunoassays, Flow, Rapid, Molecular) $ millions
    • Table Selected International Agreements
  • Company Profiles
    • 20/20 GENESYSTEMS, INC.
    • ABBOTT LABORATORIES
      • Recent Revenue History
      • Agreements
    • ABCODIA LTD.
      • Financings
    • ALERE INC. (ABBOTT)
    • AMBRY GENETICS CORP.
    • ASURAGEN, INC.
      • Diagnostic Products
      • Translational/Companion Diagnostics
      • Agreements
    • ATHENA DIAGNOSTICS, INC. (AQUEST DIAGNOSTICS BUSINESS)
    • BIOMÉRIEUX SA
      • Recent Revenue History
      • Company Overview
      • Immunodiagnostics for Lab Professionals (Clinical Laboratories)
      • Molecular Diagnostics
    • BIOTHERANOSTICS, INC. (A BIOMÉRIEUX COMPANY)
    • CANCER GENETICS, INC.
      • Recent Revenue History
      • Company Overview
      • Agreements
    • GENOMIC HEALTH, INC.
      • Recent Revenue History
    • GENOPTIX (A NOVARTIS COMPANY)
    • HOLOGIC, INC.
      • Recent Revenue History
      • Company Overview
    • ILLUMINA, INC.
      • Recent Revenue History
      • Company Overview
    • MYRIAD GENETICS, INC.
      • Recent Revenue History
      • Company Overview
    • QIAGEN N.V.
      • Recent Revenue History
    • ROCHE
      • Recent Revenue History
      • Company Overview
      • Roche Professional Diagnostics
      • Molecular Diagnostics
      • Tissue Diagnostics
    • THERMO FISHER SCIENTIFIC, INC.
      • Recent Revenue History
      • Company Overview
    • WAKO PURE CHEMICAL INDUSTRIES, LTD.,